EU Okays Afatinib for NSCLC, Filgrastim and DefibrotideEU Okays Afatinib for NSCLC, Filgrastim and Defibrotide
The European Committee for Medicinal Products for Human Use has issued new positive opinions for 3 products used to treat cancer patients. News Alerts
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Filgrastim | Health | Hematology | Neulasta | Neupogen | Non-Small Cell Lung Cancer